Asthma correctly is characterized as a syndrome rather than a disease, because a single causative mechanism has not yet been defined. This lack of definition makes the search for a cure extremely complex. Until a common pathogenetic link is identified, the possibility of a cure is remote. The precise nature of the inflammatory response in asthma has not been defined, and current concepts of the pathogenesis of asthma represent, to some extent, a reductionistic approach to a process that has been seen variously as an allergic reaction, autonomic hyperresponsiveness, or both. Additional evidence of the polygenomic nature of the disease and the inability to define a specific pathogenetic process linked to a final common pathway suggest that gene therapies probably will not be feasible, at least for the near future. As (Fig l) The second hypothesis is the "neurogenic hypoth¬ esis" of the pathogenesis of asthma. This was derived originally from Osier's conceptualization of asthma as a nervous disease. Subsequent related hypotheses included P-adrenoceptor deficiency, parasympa¬ thetic hyperresponsiveness, or both (Fig 1) . In phys¬ iologic models, P-adrenoceptor stimulation has been
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